دورية أكاديمية

51P Phase IB (Ph1b), MESOVAX clinical trial of pembrolizumab (P) and dendritic cell vaccine (DCvax) in advanced pleural and peritoneal mesothelioma (M): Preliminary results

التفاصيل البيبلوغرافية
العنوان: 51P Phase IB (Ph1b), MESOVAX clinical trial of pembrolizumab (P) and dendritic cell vaccine (DCvax) in advanced pleural and peritoneal mesothelioma (M): Preliminary results
المؤلفون: Ridolfi, L., Delmonte, A., De Rosa, F., Azzali, I., Gentili, G., Petrini, M., Pancisi, E., Granato, A.M., Bulgarelli, J., Doglioni, C., Burgio, M.A., Ragonesi, M., Stella, F., Cortesi, P., Casadei, C., Garaffoni, M., Barone, D., Guidoboni, M.
المصدر: In Immuno-Oncology and Technology December 2023 20 Supplement
قاعدة البيانات: ScienceDirect
الوصف
تدمد:25900188
DOI:10.1016/j.iotech.2023.100524